Impact of pharmaceutical care on the health-related quality of life among hemodialysis patients - A multicenter randomized controlled study.

The present study was planned to assess the impact of pharmaceutical care on the health-related quality of life (HRQoL) among hemodialysis (HD) patients. An open-label, randomized control study was carried out at three different HD centers of teaching, government, and corporate hospitals in South India. The patients were randomized into two groups (Usual Care Group [UC] and Pharmaceutical Care Group [PC]) by block design method.

Pharmacoeconomic evaluation of hospitalised pre-dialysis and dialysis patients: A comparative study.

Background: The progression of chronic kidney disease (CKD) can be attributed to various factors, including lack of medical services, delayed referral, lack of awareness about the disease, drugs, and financial support.

Aims: To compare the pharmacoeconomic-related direct medical and non-medical costs among hospitalised pre-dialysis and dialysis patients.

Methods: A prospective observational study was conducted on the inpatients admitted to the Department of Nephrology.